Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shareholders concerns are valid.....
We all know the perils of OTC trading and the murmur of shenanigans of the MM's. Having held PTSC for over 8 years I have seen constant examples of where the rules of Hoyle seem to have been broken. Having said that, I also have not seen significant large block trading that would suggest an interest is accumulating shares at this discount price. If a specific interest was accumulating a hefty percentage I believe we would know. IMO, the share price is a symptom of many factors. First this company is listed on the pennies. They don't call it the pennies for nothing. LOL. Second, PTSC story is still unknown. This you can blame on PTSC/TPL and of course their Pr firm. The best use of money right now would be to get rid of Hawk and pony up payment to a firm that knows what they are doing. Third, investors need to feel that PTSC is more than a one trick pony. JT has suggested the next step in growth is for PTSC to acquire one or more companies. I believe they should be prudent in their research but sometime in 2008 they will need to pull the trigger. Alternate revenue streams would go along way in gaining interest and confidence in this stock.

Fourth, investors need to know real numbers. We will know soon enough what those numbers are.

Casey

Share
New Message
Please login to post a reply